Treatment of idiopathic membranous nephropathy.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 22859855.
- Also identified by PMC identifier 3458460.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Exciting progress recently has been made in our understanding of idiopathic membranous nephropathy, as well as treatment of this disease. Here, we review important advances regarding the pathogenesis of membranous nephropathy. We will also review the current approach to treatment and its limitations and will highlight new therapies that are currently being explored for this disease including Rituximab, mycophenolate mofetil, and adrenocorticotropic hormone, with an emphasis on results of the most recent clinical trials.
Medical subject headings
- Glomerulonephritis, Membranous